Cost‐effectiveness analysis of tenofovir/emtricitabine and abacavir/lamivudine in combination with efavirenz or atazanavir/ritonavir for treatment‐naïve adults with<scp>HIV</scp>‐1 infection in the<scp>UK</scp>, based on the<scp>AIDS</scp>Clinical Trials Group 5202 clinical trial

Ed Wilkins, Elizabeth M. La|HIV Medicine|2015

Cited by 7